Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-10

Clinical Trial Update: A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines

View source ↗

Summary

This report summarizes a retrospective study evaluating the effectiveness and benefit of onabotulinumtoxinA (Botox) in patients with chronic migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Chronic Migraine, Headaches | Status: COMPLETED | Results posted: 2015-09-10